European Archives - Page 1005 of 1554 - European Medical Journal

Blood-Brain Barrier-Crossing Antihypertensive Medications Linked to Less Memory Decline in Older Adults

A recent meta-analysis is the first of its kind to assess the potential cognitive benefits over time of blood-brain barrier-crossing renin-angiotensin system drugs compared with their nonpenetrant counterparts.

Rare Cases of Myocarditis Following mRNA COVID-19 Vaccination

a retrospective case series evaluated individuals enrolled in the United States’ Military Health System who experienced myocarditis symptoms within 4 days (12–96 hours) of receiving the second dose of a mRNA COVID-19 vaccine.

Microbiol & Infect Dis CP

Disseminated Phaeohyphomycotic Lymphadenitis with Cladophialophora Species

This communication reports a case of subcutaneous phaeohyphomycosis with disseminated lymphadenitis caused by Cladophialophora species.

EMJ Podcast: Medicine and Martial Arts

We sit down with Dr. Michael Peck, together we consider the important relationship between surgeon, anaesthesiologist, and patient and explore life lessons he has learnt from practising karate.

EMJ Podcast: Latest Developments in RET-driven lung cancer

This podcast explores the latest developments in RET‑driven lung cancer that were presented at the American Society of Clinical Oncology’s (ASCO) 2021 virtual conference.

Differences in Low-Density Lipoprotein Particle Composition and Oxidation May Underlie the Paradoxical Association of Low Levels with Higher Coronary Atherosclerosis Burden in Rheumatoid Arthritis

Differences in Low-Density Lipoprotein Particle Composition and Oxidation May Underlie the Paradoxical Association of Low Levels with Higher Coronary Atherosclerosis Burden in Rheumatoid Arthritis

In fact, patients with RA in the lowest low-density lipoprotein (LDL) group (<70 mg/dL) may experience an unexpectedly high CVD risk.2 The authors explored whether patients with LDL 130 mg/dL), as a reason for this risk.

Rheumatology Feature Image

EMJ Rheumatology 8.1 2021

Welcome to the latest issue of EMJ Rheumatology! We are pleased to share with you a collection of the latest rheumatology insights, peer-reviewed research, and exclusive interviews with experts in the field, alongside our review of the European League Against Rheumatism (EULAR) Congress 2021 with research updates and news from the virtual event.

Rheumatology Feature Image

Review of the European Alliance of Associations for Rheumatology (EULAR) 2021 Virtual Congress

Virtual again… once more the European Alliance of Associations for Rheumatology (EULAR) took the decision to hold their prestigious annual…

Rheumatology Feature Image

Artificial Intelligence in Rheumatic Diseases: Can It Solve the Treatment Management Puzzle?

This symposium was developed to consider the future role that AI might play in the management of rheumatic diseases. First, Ignacio Medrano considered the current use of AI in healthcare and its possible future applications.

Managing Chronic Pain in Osteoarthritis and Rheumatoid Arthritis

ON DAY 3 of the European Alliance of Associations for Rheumatology (EULAR) 2021 Congress, participants from across the globe accessed the virtual platform to join Jon Lampa, Associate Professor, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, and his panel as they explored the challenges and opportunities of managing chronic pain in osteoarthritis and rheumatoid arthritis.